Frequency and Outcome in Patients Presenting with NSTEMI Undergoing PCI for MV Coronary Artery Disease in Index Hospitalization at Tertiary Care Hospital, Karach

Authors

  • Awais Shafi Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.
  • Khursheed Hassan Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.
  • Muhammad Amin Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.
  • Abdul Sami Ansar Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.
  • Ramesh Das Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.
  • Cheena Kumari Department of Cardiology, Tabba Heart Institute, Karachi, Sindh, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i6.2721

Keywords:

NSTEMI, Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention, In-hospital Mortality, Cardiovascular Risk Factors.

Abstract

Background: Multivessel coronary artery disease (MVD) in patients with Non-ST Elevation Myocardial Infarction (NSTEMI) presents a significant clinical challenge, influencing treatment decisions and patient outcomes. Understanding the frequency of MVD and its impact on in-hospital mortality can help guide more effective management strategies. Objective:  To determine the frequency and outcome in patients presenting with NSTEMI undergoing PCI for MV coronary artery disease in index hospitalization at Tertiary Care Hospital, Karachi. Methods: This retrospective, observational study analyzed 133 patients diagnosed with NSTEMI who underwent PCI. Baseline characteristics, comorbidities, lifestyle factors, and socioeconomic status were compared between patients with and without MVD. The primary outcomes were the frequency of MVD and in-hospital mortality. Statistical analyses assessed associations between patient characteristics and outcomes. Results: Multivessel disease was present in 36.1% of patients. Significant differences were observed in residence status (P = 0.01), smoking (P = 0.01), hypertension (P = 0.04), dyslipidemia (P = 0.01), family history of coronary artery disease (P = 0.01), and income levels (P = 0.01) between the MVD and non-MVD groups. In-hospital mortality was 20.3%, with a higher incidence among MVD patients. Conclusion: NSTEMI patients with MVD face a higher risk of in-hospital mortality, particularly those from rural areas, smokers, and lower-income groups. Early diagnosis, targeted prevention, and optimized treatment strategies are crucial for improving outcomes. Further research is needed to assess long-term effects and refine management approaches for high-risk patients.

Downloads

Download data is not yet available.

References

1. Fox, K. A., Eagle, K. A., Gore, J. M., Steg, P. G., & Anderson, F. A. (2010). The global registry of acute coronary events, 1999 to 2009–GRACE. Heart, 96(14), 1095-1101.

https://doi.org/10.1136/hrt.2009.190827

2. Yeh, R. W., Sidney, S., Chandra, M., Sorel, M., Selby, J. V., & Go, A. S. (2010). Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medicine, 362(23), 2155-2165.

https://doi.org/10.1056/nejmoa0908610

3. Hashmi, K. A., Abbas, K., Hashmi, A. A., Irfan, M., Edhi, M. M., Ali, N., & Khan, A. (2018). In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization. BMC Research Notes, 11(1).

https://doi.org/10.1186/s13104-018-3830-7

4. Brener, S. J., Milford-Beland, S., Roe, M. T., Bhatt, D. L., Weintraub, W. S., & Brindis, R. G. (2008). Culprit-only or multivessel revascularization in patients with acute coronary syndromes. American Heart Journal, 155(1), 140-146.

https://doi.org/10.1016/j.ahj.2007.09.007

5. O'Keefe, J. H., Rutherford, B. D., McConahay, D. R., Johnson, W. L., Giorgi, L. V., Ligon, R. W., Shimshak, T. M., & Hartzler, G. O. (1990). Multivessel coronary angioplasty from 1980 to 1989: Procedural results and long-term outcome. Journal of the American College of Cardiology, 16(5), 1097-1102.

https://doi.org/10.1016/0735-1097(90)90538-z

6. Rodriguez, A., Bernardi, V., & Navia, J. (2001). Argentine randomized study: Coronary angioplasty with stenting vs. coronary artery bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one year follow-up results. ACC Current Journal Review, 10(4), 63.

https://doi.org/10.1016/s1062-1458(01)00321-x

7. Hashmi, K. A., Saeed, H. Y., Ahmed, J., Najam, J., Irfan, M., & Hashmi, A. (2020). Left ventricular thrombus formation in acute anterior wall myocardial infarction: A comparison between Thrombolyzed and non-thrombolyzed patients. Cureus.

https://doi.org/10.7759/cureus.9090

8. Serruys, P. W., Morice, M., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., Van den Brand, M., Bass, E. J., Van Dyck, N., Leadley, K., Dawkins, K. D., & Mohr, F. W. (2009). Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New England Journal of Medicine, 360(10), 961-972.

https://doi.org/10.1056/nejmoa0804626

9. Jaski, B. E., Cohen, J. D., Trausch, J., Marsh, D. G., Bail, G. R., Overlie, P. A., Skowronski, E. W., & Smith, S. C. (1992). Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: Comparison of single-vessel versus multivessel coronary artery disease. American Heart Journal, 124(6), 1427-1433.

https://doi.org/10.1016/0002-8703(92)90053-x

10. Sorajja, P., Gersh, B. J., Cox, D. A., McLaughlin, M. G., Zimetbaum, P., Costantini, C., Stuckey, T., Tcheng, J. E., Mehran, R., Lansky, A. J., Grines, C. L., & Stone, G. W. (2007). Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. European Heart Journal, 28(14), 1709-1716.

https://doi.org/10.1093/eurheartj/ehm184

11. Ben-Gal, Y., Moses, J. W., Mehran, R., Lansky, A. J., Weisz, G., Nikolsky, E., Argenziano, M., Williams, M. R., Colombo, A., Aylward, P. E., & Stone, G. W. (2010). Surgical versus percutaneous Revascularization for Multivessel disease in patients with acute coronary syndromes. JACC: Cardiovascular Interventions, 3(10), 1059-1067.

https://doi.org/10.1016/j.jcin.2010.06.017

12. Hashmi, K. A., Saeed, H. Y., Farid, M. S., Najam, J., Irfan, M., & Hashmi, A. (2020). Frequency of Multivessel severe coronary artery disease in patients with Non-ST segment elevation myocardial infarction having markedly raised cardiac troponin T. Cureus.

https://doi.org/10.7759/cureus.9571

13. Shishehbor, M. H., Lauer, M. S., Singh, I. M., Chew, D. P., Karha, J., Brener, S. J., Moliterno, D. J., Ellis, S. G., Topol, E. J., & Bhatt, D. L. (2007). In unstable angina or non–st-segment acute coronary syndrome, should patients with Multivessel coronary artery disease undergo Multivessel or culprit-only stenting? Journal of the American College of Cardiology, 49(8), 849-854.

https://doi.org/10.1016/j.jacc.2006.10.054

14. Myat A, Chioncel O, Mebazaa A, et al. Acute coronary syndrome: The importance of early detection and treatment. Lancet. 2017;389(10076):2213-2223.

15. Patel S, Zieske AW, Hecht HS. Age and coronary artery disease severity: Implications for prevention and treatment. JAMA. 2020;323(9):815-824.

16. Camici PG, Fuster V. Gender and coronary artery disease: Insights from clinical research. N Engl J Med. 2020;383(6):531-544.

17. Vaccarino V, O'Neill L. Gender differences in the burden of coronary artery disease: A review. Circulation. 2017;135(16):1410-1416.

18. García-Álvarez A, Pérez-Vázquez A. Rural versus urban disparities in healthcare outcomes for cardiovascular diseases. Am Heart J. 2019;218:125-134.

19. Hughes A, Roberts L, Anderson M. Geography and cardiovascular health: A population-based study. Int J Cardiol. 2018;269:1-7.

20. Oliveira GS, de Moura P, Silva AA. Urbanization and lifestyle: Key determinants of coronary artery disease. Rev Port Cardiol. 2019;38(10):677-684.

21. Cohn JN, Morrissey R. The role of hypertension in coronary artery disease. Am J Cardiol. 2018;121(6):756-764.

22. Chong V, Lopez A, Martin G. Hypertension and coronary artery disease: A review of management strategies. J Clin Hypertens. 2019;21(4):460-469.

23. Nichols M, Townsend N, Scarborough P. Hypertension, dyslipidemia, and coronary artery disease: The relationship with patient outcomes. BMJ Open. 2020;10(1):e035119.

24. Yazdanpanah M, Gharipour M, Rafiee F. Diabetes and coronary artery disease: A review of mechanisms and treatment options. Cardiovasc Diabetol. 2020;19(1):82.

25. Singh S, Puri R, Soni P. Diabetes mellitus and coronary artery disease: The epidemiological challenges. Diabetes Care. 2021;44(3):504-513.

26. Gaede P, Vedel P, Larsen N. The influence of smoking on coronary artery disease. Arch Intern Med. 2021;181(7):953-960.

27. Lopez-Vidriero A, Moliner G. Smoking and cardiovascular disease: Pathophysiology and risk reduction. Am J Cardiol. 2020;125(3):420-428.

28. Johnson K, Smith J. Family history as a predictor of coronary artery disease. JAMA Cardiol. 2021;6(10):1234-1242.

29. Marmot M, Stansfeld S, Stuckler D. Social determinants of health and cardiovascular disease. Lancet. 2017;390(10097):1-10.

30. Das S, Singh M. Socioeconomic disparities in cardiovascular outcomes. Heart. 2020;106(6):432-437.

31. Goff DC, Lloyd-Jones D, Bennett G. The burden of coronary artery disease: A contemporary perspective. Circulation. 2018;137(9):1034-1042.

32. Blomberg J, Linder R, Stråhle R. In-hospital outcomes in NSTEMI patients with multivessel disease. Am Heart J. 2019;218:120-126.

Downloads

Published

2025-06-30

How to Cite

Shafi, A., Hassan, K., Muhammad Amin, Ansar, A. S., Das, R., & Kumari, C. (2025). Frequency and Outcome in Patients Presenting with NSTEMI Undergoing PCI for MV Coronary Artery Disease in Index Hospitalization at Tertiary Care Hospital, Karach. Indus Journal of Bioscience Research, 3(6), 1263-1268. https://doi.org/10.70749/ijbr.v3i6.2721